Drug to treat agitation in Alzheimer's patients approved in Canada - National

Health Canada has approved an oral drug to treat symptoms of agitation associated with dementia due to Alzheimer’s disease in patients.

Related Keywords

United States ,Canada ,Michael Laranjo ,Drug Administration ,Young ,Alzheimer Society Of Canada ,Otsuka Pharmaceutical Canada Inc ,Health Canada ,Lundbeck Canada Inc ,Otsuka Pharmaceutical Canada ,Lundbeck Canada ,Otsuka Canada ,Alzheimer 039s Disease ,Odd ,Alzheimer 039s Drug ,Health ,